If you need more lookups,
subscriptions start at $34 USD/month.
Xiang Ye Location
Shanghai, CN
Xiang Ye Work
2025 -now Chief Executive Officer and Chief Scientific Officer @
2023 -now Chief Scientific Officer @
2022 -2023 Chief Scientific Officer @
2018 -2023 Executive Director of Cancer Research China and Asia @ Eli Lilly
2008 -2023 Senior Research Advisor @ Eli Llly and Co.
1997 -1998 Senior Biologist @ American Home Product
Xiang Ye Education
The University of Sydney, Australia
Doctor of Philosophy (PhD) (Cell/Cellular and Molecular Biology)
1983-1987
Central China Agriculture University
Bachelor of Science (BS) (Agriculture, General)
1977-1982
Xiang Ye Skills
Drug Discovery
Biomarkers
Oncology
Drug Development
Clinical Development
Biotechnology
CRO
Lifesciences
Pharmaceutical Industry
Pharmacology
Protein Chemistry
Clinical Trials
Assay Development
Biochemistry
Medicinal Chemistry
Vaccines
Genomics
Molecular Biology
In Vivo
Cancer
Chromatography
Pharmacokinetics
Purification
High Throughput Screening
Bioinformatics
In Vitro
Translational Medicine
Antibodies
Neuroscience
Animal Models
Biomarker Discovery
ADME
Toxicology
Biopharmaceuticals
Cell
Drug Metabolism
Lead Change
Drug Design
GLP
Pharmacodynamics
Signal Transduction
Cancer Research
Immunology
Cell Biology
LC-MS
IND
Infectious Diseases
Target Identification
HPLC
Technology Transfer
Lc Ms
Xiang Ye Summary
Xiang Ye, based in Shanghai, CN, is currently a Chief Executive Officer and Chief Scientific Officer at AlphaGen Therapeutics. Xiang Ye brings experience from previous roles at Perpetual Medicines, Risen Pharma, Eli Lilly and Eli Llly and Co.. Xiang Ye holds a 1983 - 1987 Doctor of Philosophy (PhD) in Cell/Cellular and Molecular Biology @ The University of Sydney, Australia. With a robust skill set that includes Drug Discovery, Biomarkers, Oncology, Drug Development, Clinical Development and more. Xiang Ye has 1 emails on RocketReach.
Looking for a different Xiang Ye?
Find contact details for 700 million professionals.